142 related articles for article (PubMed ID: 1381239)
1. Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome.
Backx B; Broeders L; Löwenberg B
Blood; 1992 Sep; 80(5):1213-7. PubMed ID: 1381239
[TBL] [Abstract][Full Text] [Related]
2. Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.
Backx B; Broeders L; Hoefsloot LH; Wognum B; Löwenberg B
Leukemia; 1996 Mar; 10(3):466-72. PubMed ID: 8642863
[TBL] [Abstract][Full Text] [Related]
3. The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes.
Verbeek W; Vehmeyer K; Wörmann B; Hiddemann W
J Cancer Res Clin Oncol; 1995; 121(6):338-42. PubMed ID: 7797598
[TBL] [Abstract][Full Text] [Related]
4. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
[TBL] [Abstract][Full Text] [Related]
5. In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
Zwierzina H; Bammer T; Rollinger-Holzinger I; Herold M; Fenaux P; Nüssler V; Hoflehner E; Geissler D
Clin Cancer Res; 1996 Jun; 2(6):1031-8. PubMed ID: 9816264
[TBL] [Abstract][Full Text] [Related]
6. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
[TBL] [Abstract][Full Text] [Related]
7. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
[TBL] [Abstract][Full Text] [Related]
8. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
9. CD34+/CD36- cells from myelodysplasia patients have a limited capacity to proliferate but can differentiate in response to Epo and MGF stimulation.
Brada SJ; de Wolf JT; Hendriks DW; Smit JW; Vellenga E
Leukemia; 1998 Jun; 12(6):882-6. PubMed ID: 9639415
[TBL] [Abstract][Full Text] [Related]
10. Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells.
Goselink HM; Williams DE; Fibbe WE; Wessels HW; Beverstock GC; Willemze R; Falkenburg JH
Blood; 1992 Aug; 80(3):750-7. PubMed ID: 1638026
[TBL] [Abstract][Full Text] [Related]
11. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
[TBL] [Abstract][Full Text] [Related]
12. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
13. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
14. Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells.
Sawada K; Ieko M; Notoya A; Tarumi T; Koizumi K; Kitayama S; Nishio H; Fukada Y; Yasukouchi T; Yamaguchi M; Katoh S; Koike T
Blood; 1996 Jul; 88(1):319-27. PubMed ID: 8704190
[TBL] [Abstract][Full Text] [Related]
15. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
Gabbianelli M; Pelosi E; Montesoro E; Valtieri M; Luchetti L; Samoggia P; Vitelli L; Barberi T; Testa U; Lyman S
Blood; 1995 Sep; 86(5):1661-70. PubMed ID: 7544638
[TBL] [Abstract][Full Text] [Related]
16. Increased peripheral stem cell pool in MDS: an indication of disease progression?
Vehmeyer K; Haase D; Alves F
Leuk Res; 2001 Nov; 25(11):955-9. PubMed ID: 11597730
[TBL] [Abstract][Full Text] [Related]
17. Effect of stem cell factor (c-kit ligand) on clonogenic leukemic precursor cells: synergy with other hematopoietic growth factors.
Wu HK; Chiba S; Hirai H; Takaku F; Yazaki Y
Am J Hematol; 1994 Dec; 47(4):328-30. PubMed ID: 7526682
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor.
Brada SJ; de Wolf JT; Hendriks D; Louwes H; van den Berg E; Vellenga E
Leukemia; 1998 Mar; 12(3):340-5. PubMed ID: 9529128
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
[TBL] [Abstract][Full Text] [Related]
20. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
Sato T; Kim S; Selleri C; Young NS; Maciejewski JP
Leukemia; 1998 Aug; 12(8):1187-94. PubMed ID: 9697872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]